HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progressive multifocal leukoencephalopathy in an HIV-negative patient following treatment with rituximab.

AuthorsShafik Khoury, Shirley Shapira, Tal Zilberman, Yoseph A Mekori, Alon Y Hershko
JournalThe Israel Medical Association journal : IMAJ (Isr Med Assoc J) Vol. 15 Issue 6 Pg. 321-2 (Jun 2013) ISSN: 1565-1088 [Print] Israel
PMID23882904 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
Topics
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage, adverse effects)
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Cerebrospinal Fluid (virology)
  • Confusion (diagnosis, etiology)
  • Fatal Outcome
  • Humans
  • JC Virus (physiology)
  • Leukoencephalopathy, Progressive Multifocal (diagnosis, etiology, physiopathology)
  • Lymphoma, Large B-Cell, Diffuse (drug therapy)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Psychomotor Agitation (diagnosis, etiology)
  • Rituximab
  • Tomography, X-Ray Computed (methods)
  • Virus Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: